"Drug Utilization Review" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.
| Descriptor ID |
D017723
|
| MeSH Number(s) |
N04.452.706.477.400 N04.761.879.300 N05.700.900.300
|
| Concept/Terms |
Drug Utilization Review- Drug Utilization Review
- Evaluation, Drug Utilization
- Drug-Use Review
- Drug Use Review
- Drug-Use Reviews
- Reviews, Drug-Use
- Review, Drug Utilization
- Drug Utilization Reviews
- Reviews, Drug Utilization
- Utilization Reviews, Drug
- Utilization Review, Drug
- Drug Utilization Evaluation
- Drug Utilization Evaluations
- Evaluations, Drug Utilization
- Utilization Evaluation, Drug
- Utilization Evaluations, Drug
- Review, Drug-Use
- Review, Drug Use
|
Below are MeSH descriptors whose meaning is more general than "Drug Utilization Review".
Below are MeSH descriptors whose meaning is more specific than "Drug Utilization Review".
This graph shows the total number of publications written about "Drug Utilization Review" by people in this website by year, and whether "Drug Utilization Review" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 6 | 13 | 19 |
| 2018 | 7 | 5 | 12 |
| 2019 | 6 | 1 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Utilization Review" by people in Profiles.
-
Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic. JAMA Netw Open. 2021 05 03; 4(5):e2110775.
-
[Drug use during the covid-19 pandemic in Italy.] Recenti Prog Med. 2021 05; 112(5):338-342.
-
Drug-utilisation profiles and COVID-19. Sci Rep. 2021 04 26; 11(1):8913.
-
Antibiotic prescriptions in Italian hospitalised children after serial point prevalence surveys (or pointless prevalence surveys): has anything actually changed over the years? Ital J Pediatr. 2019 Oct 17; 45(1):127.
-
Antimicrobial utilization data: Does point prevalence data correlate with defined daily doses? Infect Control Hosp Epidemiol. 2019 08; 40(8):920-921.
-
Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implications. Hosp Pract (1995). 2019 Apr; 47(2):88-95.
-
Antimicrobial stewardship: an evaluation of structure and process and their association with antimicrobial prescribing in NHS hospitals in England. J Antimicrob Chemother. 2019 04 01; 74(4):1143-1152.
-
Impact of Chief Medical Officer activity on prescribing of antibiotics in England: an interrupted time series analysis. J Antimicrob Chemother. 2019 04 01; 74(4):1133-1136.
-
Assessment of vancomycin utilization among Lebanese hospitals. Saudi Med J. 2019 Feb; 40(2):152-157.
-
One-Year Persistence with Donepezil, Memantine, and Rivastigmine in More than 66,000 Elderly Patients Followed in Poland. J Alzheimers Dis. 2019; 70(3):899-905.